Argosy Research (3217) — Capital Reinvestment Ratio
Argosy Research (3217) has a Capital Reinvestment Ratio of 0.13x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$515.08 Million) in capital expenditures (NT$66.48 Million). See how leveraged is Argosy Research's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Argosy Research Capital Reinvestment Ratio (2017–2025)
This chart tracks Argosy Research's Capital Reinvestment Ratio across 9 annual periods. Check 3217 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Argosy Research (2017–2025)
Year-by-year Capital Reinvestment Ratio for Argosy Research from 2017 to 2025. For live market cap and broader valuation context, see 3217 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | NT$1.26 Billion | NT$217.61 Million | ▲ +26.2% |
| 2024 | 0.14x | NT$1.01 Billion | NT$138.32 Million | ▼ -52.6% |
| 2023 | 0.29x | NT$764.74 Million | NT$220.53 Million | ▲ +72.3% |
| 2022 | 0.17x | NT$876.97 Million | NT$146.78 Million | ▼ -70.7% |
| 2021 | 0.57x | NT$595.58 Million | NT$340.50 Million | ▲ +149.4% |
| 2020 | 0.23x | NT$738.04 Million | NT$169.17 Million | ▲ +51.6% |
| 2019 | 0.15x | NT$572.03 Million | NT$86.47 Million | ▼ -48.2% |
| 2018 | 0.29x | NT$239.07 Million | NT$69.82 Million | ▲ +13.6% |
| 2017 | 0.26x | NT$351.05 Million | NT$90.25 Million | — |